PMID- 34863210
OWN - NLM
STAT- MEDLINE
DCOM- 20211209
LR  - 20211214
IS  - 1742-6405 (Electronic)
IS  - 1742-6405 (Linking)
VI  - 18
IP  - 1
DP  - 2021 Dec 4
TI  - Adverse events of inactivated COVID-19 vaccine in HIV-infected adults.
PG  - 92
LID - 10.1186/s12981-021-00416-1 [doi]
LID - 92
AB  - This study aims to evaluate the safety of inactivated COVID-19 vaccine among 
      adult people living with HIV (PLWH). In total, 259 PLWH who received at least one 
      dose of inactivated COVID-19 vaccine were enrolled, and post-vaccination adverse 
      events (AEs) were evaluated seven days following each vaccination dose. The 
      overall AE frequency was 22.8% after dose one, which was higher than after dose 
      two (10.2%) (P < 0.001). No severe side event or vaccine safety concern was 
      observed. Our finding was essential in reducing vaccine hesitancy among PLWH.
CI  - (c) 2021. The Author(s).
FAU - Wu, Songjie
AU  - Wu S
AD  - Department of Nosocomial Infection Management, Zhongnan Hospital of Wuhan 
      University, Wuhan, Hubei, China.
FAU - Zhang, Yubin
AU  - Zhang Y
AD  - Wuchang District Center for Disease Control and Prevention, Wuhan, Hubei, China.
FAU - Ming, Fangzhao
AU  - Ming F
AD  - Wuchang District Center for Disease Control and Prevention, Wuhan, Hubei, China.
FAU - Zou, Shi
AU  - Zou S
AD  - Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Wuhan, 
      Hubei, China.
FAU - Wu, Mengmeng
AU  - Wu M
AD  - Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Wuhan, 
      Hubei, China.
FAU - Guo, Wei
AU  - Guo W
AD  - Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, China.
AD  - Department of Pathology, School of Basic Medical Sciences, Wuhan University, 
      Wuhan, China.
FAU - Tang, Weiming
AU  - Tang W
AD  - Guangdong No. 2 Provincial People's Hospital, University of North Carolina at 
      Chapel Hill Project-China, Guangzhou, 510095, China. Weiming_tang@med.unc.edu.
AD  - The University of North Carolina at Chapel Hill Project-China, Guangzhou, China. 
      Weiming_tang@med.unc.edu.
FAU - Liang, Ke
AU  - Liang K
AUID- ORCID: 0000-0003-0490-5328
AD  - Department of Nosocomial Infection Management, Zhongnan Hospital of Wuhan 
      University, Wuhan, Hubei, China. keliang@whu.edu.cn.
AD  - Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Wuhan, 
      Hubei, China. keliang@whu.edu.cn.
AD  - Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of 
      Medical Sciences, Wuhan, China. keliang@whu.edu.cn.
AD  - Center of Preventing Mother-To-Child Transmission for Infectious Diseases, 
      Zhongnan Hospital of Wuhan University, Wuhan, China. keliang@whu.edu.cn.
AD  - Department of Nosocomial Infection Management, Department of Infectious 
      DiseasesCenter of Preventing Mother-To-Child Transmission for Infectious 
      Diseases, Wuhan Research Center for Infectious Diseases and CancerChinese Academy 
      of Medical Sciences, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. 
      keliang@whu.edu.cn.
LA  - eng
GR  - 2017YFE0103800/the National Key Research and Development Program of China/
GR  - 81903371/the National Nature Science Foundation of China/
GR  - 2020KZDZX1047/Special Found on Prevention and Control of New Coronary Pneumonia 
      in Guangdong Universities/
GR  - 2018ZX10101-001-001-003/the National Science and Technology Major Project/
GR  - cxpy2017043/Science and Technology Innovation Cultivation Fund of Zhongnan 
      Hospital, Wuhan University/
GR  - TFJC2018004/Medical Science Advancement Program (Basic Medical Sciences) of Wuhan 
      University/
GR  - R34MH119963/MH/NIMH NIH HHS/United States
GR  - PTXM2020008/Medical Science and Technology Innovation Platform Support Project of 
      Zhongnan Hospital, Wuhan University/
PT  - Journal Article
DEP - 20211204
PL  - England
TA  - AIDS Res Ther
JT  - AIDS research and therapy
JID - 101237921
RN  - 0 (COVID-19 Vaccines)
SB  - IM
MH  - Adult
MH  - *COVID-19
MH  - COVID-19 Vaccines
MH  - *HIV Infections
MH  - Humans
MH  - SARS-CoV-2
MH  - Vaccination Hesitancy
PMC - PMC8643182
OTO - NOTNLM
OT  - Adverse event
OT  - COVID-19
OT  - Inactivated vaccine
OT  - People living with HIV(PLWH)
COIS- The authors declare that they have no competing interests.
EDAT- 2021/12/06 06:00
MHDA- 2021/12/15 06:00
PMCR- 2021/12/04
CRDT- 2021/12/05 20:40
PHST- 2021/08/19 00:00 [received]
PHST- 2021/11/17 00:00 [accepted]
PHST- 2021/12/05 20:40 [entrez]
PHST- 2021/12/06 06:00 [pubmed]
PHST- 2021/12/15 06:00 [medline]
PHST- 2021/12/04 00:00 [pmc-release]
AID - 10.1186/s12981-021-00416-1 [pii]
AID - 416 [pii]
AID - 10.1186/s12981-021-00416-1 [doi]
PST - epublish
SO  - AIDS Res Ther. 2021 Dec 4;18(1):92. doi: 10.1186/s12981-021-00416-1.